AIM•benzinga•
Looking Into AIM ImmunoTech's Return On Capital Employed
Summary
AIM ImmunoTech (AMEX:AIM) brought in sales totaling $30 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 26.99%, resulting in a loss of $4.85 million.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 12, 2022 by benzinga